Factors Associated Multidrug-Resistant Mycobacterium Tuberculosis in Pulmonary Tuberculosis Patients

Francis JR, Manchikanti P, Blyth CC, Denholm J, Lowbridge C, Coulter C, et al. Multidrug-resistant tuberculosis in Australia, 1998-2012. Int J Tuberc Lung 2018 1;22:294 - 9.

Bastos ML, Cosme LB, Fregona G, do Prado TN, Bertolde AI, Zandonade E, et al. Treatment outcomes of MDRtuberculosis patients in Brazil: a retrospective cohort analysis. BMC Infect Dis 2017;17:718.

Jenkins HE, Tolman AW, Yuen CM, Parr JB, Keshavjee S, Pérez-Vélez CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet 2014 ;383:1572 - 9.

Baird T, Donnan E, Coulter C, Simpson G, Konstantinos A, Eather G. Multidrug-resistant tuberculosis in Queensland, Australia: an ongoing cross-border challenge. Int J Tuberc 2018 1;22:206 - 11.

Devaux I, Manissero D, Fernandez de la Hoz K, Kremer K, van Soolingen D, EuroTB network. Surveillance of extensively drug-resistant tuberculosis in Europe, 2003-2007. Euro Surveill 2010;15. 301-20.

Seung KJ, Keshavjee S, Rich ML. Multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis. Cold Spring HarbPerspect Med 2015;5:a017863.

Dean AS, Cox H, Zignol M. Epidemiology of Drug-resistant tuberculosis. Adv Exp Med Biol 2017;1019:209 - 20.

Sinha P, Srivastava GN, Gupta A, Anupurba S. Association of risk factors and drug resistance pattern in tuberculosis patients in north India. J Glob Infect Dis 2017;9:139 - 45.

Lu P, Ding X, Liu Q, Lu W, Martinez L, Sun J, et al. Mediating effect of repeated tuberculosis exposure on the risk of transmission to household contacts of multidrug-resistant tuberculosis patients. Am J Trop Med Hyg 2018;98:364 - 71.

Liu Q, Lu P, Martinez L, Yang H, Lu W, Ding X, et al. Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China. BMC Infect Dis 2018;18:114.

Park HO, Kim SH, Moon SH, Byun JH, Kim JW, Lee CE, et al. Association between body mass index and sputum culture conversion among south Korean patients with multidrug resistant tuberculosis in a tuberculosis referral hospital. Infect Chemother 2016;48:317 - 23.

Salindri AD, Kipiani M, Kempker RR, Gandhi NR, Darchia L, Tukvadze N, et al. Diabetes reduces the rate of sputum culture conversion in patients with newly diagnosed multidrug-resistant tuberculosis. Open Forum Infect Dis 2016 ;3:ofw126.

Gomes T, Vinhas SA, Reis-Santos B, Palaci M, Peres RL, Aguiar PP, et al. Extrapulmonary tuberculosis: Mycobacterium tuberculosis strains and host risk factors in a large urban setting in Brazil. PloS One 2013;8:e74517.

Aibana O, Bachmaha M, Krasiuk V, Rybak N, Flanigan TP, Petrenko V, et al. Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine. BMC Infect Dis 2017; 17:129.

Adane K, Ameni G, Bekele S, Abebe M, Aseffa A. Prevalence and drug resistance profile of Mycobacterium tuberculosis isolated from pulmonary tuberculosis patients attending two public hospitals in East Gojjam zone, northwest Ethiopia. BMC Public Health 2015;15:572.

Mekonnen F, Tessema B, Moges F, Gelaw A, Eshetie S, Kumera G. Multidrug resistant tuberculosis: prevalence and risk factors in districts of metema and west armachiho, Northwest Ethiopia. BMC Infect Dis 2015;15:461.

Guglielmetti L, Veziris N, Aubry A, Brossier F, Bernard C, Sougakoff W, et al. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study. Int J Tuberc 2018 ;22:54 - 9.

Fregona G, Cosme LB, Moreira CMM, Bussular JL, Dettoni VDV, Dalcolmo MP, et al. Risk factors associated with multidrug-resistant tuberculosis in Espírito Santo, Brazil. Rev Saude Publica 2017;51:41.

Andrews JR, Shah NS, Weissman D, Moll AP, Friedland G, Gandhi NR. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community.PloS One 2010 ;5:e15735.

Boonsarngsuk V, Mangkang K, Santanirand P. Prevalence and risk factors of drug-resistant extrapulmonary tuberculosis. Clin Respir J 2018; 12:2101-9.

Schlesselman JJ. Sample size calculation match Case-Control Studies. New York: Oxford University Press; 1982.

Javaid A, Ullah I, Masud H, Basit A, Ahmad W, Butt ZA, et al. Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study. Clin Microbiol Infect 2018 ;24:612-7.

Thu MK, Kumar AMV, Soe KT, Saw S, Thein S, Mynit Z, et al. High treatment success rate among multidrug-resistant tuberculosis patients in Myanmar, 2012-2014: a retrospective cohort study. Trans R Soc Trop Med Hyg 2017;111:410 - 7.